About
Treatments for Cardiometabolic Diseases
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBiotech
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
338
By Phase
PHASE2: 2PHASE1: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07199309Lead Sponsor
A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
PHASE2Recruiting
30 participants
Started: Sep 30, 2025 · Completed: Nov 30, 2026
NCT07195175Lead Sponsor
Study of MAR002 in Healthy Men
PHASE1Recruiting
37 participants
Started: Aug 11, 2025 · Completed: May 31, 2026
NCT07028749Lead Sponsor
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
PHASE2Recruiting
216 participants
Started: Jun 30, 2025 · Completed: Dec 31, 2026
NCT05896254Lead Sponsor
Study of MAR001 in Adults With Metabolic Dysfunction
PHASE1/PHASE2Completed
55 participants
Started: Jul 22, 2023 · Completed: Dec 13, 2024
Funding History (1)
D
Jun 24, 2024
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...